Balentic news

Audax Private Equity Completes the Sale of Corsearch to Astorg

Audax Private Equity (“Audax”) today announced that it has successfully completed the sale of Corsearch to Astorg.

Sat Apr 10 2021Audax Private Equity

Charterhouse Capital Partners enters into exclusive negotiations for the sale of Cooper to CVC Capital Partners Fund VII and reinvestment in its next stage of growth

Charterhouse Capital Partners LLP has entered into exclusive negotiations for the sale of a majority stake in Cooper Consumer Health, a leading European independent over-the-counter (OTC) drug manufacturer and distributor, to CVC Fund VII. The transaction is subject to approval from relevant regulatory authorities and consultation with workers' councils.

Fri Mar 12 2021Charterhouse Capital Partners LLP

Audax Private Equity Completes Sale of Altasciences to Novo Holdings

Audax Private Equity (“Audax”) today announced that it has successfully completed the previously announced sale of Altasciences to Novo Holdings.

Fri Mar 05 2021Audax Private Equity

Charterhouse Capital Partners announces partial sale of Funecap, continues to support next phase of growth

Charterhouse Capital Partners LLP has announced the partial realisation of its investment in Funecap Groupe, a leading funeral services and crematoria provider in France, through the sale of a stake to Latour Capital.

Wed Feb 10 2021Charterhouse Capital Partners LLP

Audax Private Equity Completes the Sale of AI Fire to Snow Phipps Group

Audax Private Equity (“Audax”) has completed the sale of AI Fire, LLC (“AI Fire” or the “Company”) to Snow Phipps Group (“Snow Phipps”).

Sun Jan 31 2021Audax Private Equity

Audax Private Equity Announces Successful Closing of $1.7 billion Continuation Fund Led by AlpInvest Partners, Lexington Partners, and Hamilton Lane

Audax Private Equity (“Audax”) announced today the successful completion of its first Continuation Fund. The fund is comprised of $1.7 billion in capital commitments, which funded the purchase of portfolio companies from Audax Private Equity Fund IV, a 2012 vintage fund with $1.25 billion in capital commitments.

Sat Jan 30 2021Audax Private Equity

Audax Private Equity and Linden Capital Partners Invest in StatLab Medical Products

Audax Private Equity (“Audax”) and Linden Capital Partners (“Linden”), two leading middle-market private equity firms, announced today the acquisition of StatLab Medical Products (“StatLab” or the “Company”). Founded in 1976 and headquartered in McKinney, Texas, StatLab is a leading manufacturer and distributor of consumables, reagents, and equipment used by anatomic pathology, molecular diagnostics, and other laboratories.

Fri Jan 15 2021Audax Private Equity

Charterhouse Capital Partners announces investment in PHASTAR

Charterhouse Capital Partners LLP ("Charterhouse"), a leading private equity firm, has announced its investment in PHASTAR, a specialist provider of biostatistics and data science services for clinical trials. This partnership will see Charterhouse working alongside PHASTAR's founder and CEO, Kevin Kane, who will retain a significant shareholding and continue leading the company with its existing management team.

Tue Jan 05 2021Charterhouse Capital Partners LLP

Audax Private Equity

Boston, United States

Based in Boston and San Francisco, Audax Private Equity is a leading middle market investment firm with approximately $16 billion of assets under management, over 185 employees, and 80-plus investment professionals. Since its founding in 1999, the firm has invested in more than 160 platforms and 1,200 add-on acquisitions. Through our disciplined Buy & Build approach, across six core industry verticals, Audax helps portfolio companies execute on organic and inorganic growth initiatives that fuel revenue expansion, optimize operations, and significantly increase equity value.

buyoutprivate equity

Charterhouse Capital Partners LLP

London, United Kingdom

Charterhouse is one of the longest established private equity firms operating in Europe. The firm connects expertise and capital, partnering with ambitious founders and management teams to drive transformational change. Charterhouse has a selective, conviction-led approach to investing in high-quality mid-market European companies across the Services, Healthcare, Specialised Industrials and Consumer sectors. It targets transactions with an enterprise value of between €200m and €1.5bn. Charterhouse’s international team works in an integrated and flexible manner, allowing the firm to combine the skills, knowledge and experience of its entire team to help build successful businesses over the long term. The firm has completed more than 150 acquisitions over 35 years of activity in the European buyout market.

buyoutprivate equity